Abstract | OBJECTIVE: METHODS: RESULTS: About one-fourth of DMPA users had early weight gain. The mean weight gain of the at or below 5% group and above 5% group was 0.63 kg and 8.04 kg, 1.48 kg and 10.86 kg, and 2.49 kg and 11.08 kg after 12, 24, and 36 months (P<.001 at all observations), respectively. Early weight gainers also had a much steeper slope of weight gain over time than the regular weight gainers (0.35 kg/month compared with 0.08 kg/month, P<.001). Risk factors for early weight gain were body mass index less than 30 (odds ratio [OR] 4.00, 95% confidence interval [CI] 1.513-10.455), parity (OR 2.23, 95% CI:1.040-4.761), and self-reported increased appetite after 6 months of DMPA use (OR 3.06, 95% CI 1.505-6.214). CONCLUSION: Most DMPA users who gain excessive weight experience more than a 5% weight increase within 6 months. These data help physicians predict who is at risk of excessive gain and counsel them appropriately. LEVEL OF EVIDENCE: II.
|
Authors | Yen-Chi L Le, Mahbubur Rahman, Abbey B Berenson |
Journal | Obstetrics and gynecology
(Obstet Gynecol)
Vol. 114
Issue 2 Pt 1
Pg. 279-284
(Aug 2009)
ISSN: 0029-7844 [Print] United States |
PMID | 19622988
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Contraceptive Agents, Female
- Delayed-Action Preparations
- Medroxyprogesterone Acetate
|
Topics |
- Adolescent
- Adult
- Appetite
- Body Mass Index
- Contraceptive Agents, Female
(administration & dosage, adverse effects)
- Delayed-Action Preparations
- Female
- Humans
- Medroxyprogesterone Acetate
(administration & dosage, adverse effects)
- Parity
- Pregnancy
- Regression Analysis
- Weight Gain
(drug effects)
|